Antiaging Quantum Living Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	1.03	0.82	0.01	0.01	0.01
Revenue	1.03	0.82	0.01	0.01	0.01
Revenue Growth	26.47%	10806.76%	-44.86%	83.78%	-19.80%
Cost of Revenue	0.33	0.39	0	-	0
Gross Profit	0.7	0.43	0.01	0.01	0.01
Selling, General & Admin	1.54	1.22	0.42	0.05	0.05
Operating Expenses	1.54	1.22	0.42	0.05	0.05
Operating Income	-0.84	-0.79	-0.41	-0.04	-0.05
Interest & Investment Income	0	0	0	-	0
Other Non Operating Income (Expenses)	0.01	0.07	0	-	-
Pretax Income	-0.82	-0.72	-0.41	-0.04	-0.04
Income Tax Expense	0.02	-	-	-	-
Net Income	-0.84	-0.72	-0.41	-0.04	-0.04
Net Income to Common	-0.84	-0.72	-0.41	-0.04	-0.04
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	31	30	30	30	30
Shares Outstanding (Diluted)	31	30	30	30	30
Shares Change	4.96%	-	-	-	-
EPS (Basic)	-0.03	-0.02	-0.01	-0.00	-0.00
EPS (Diluted)	-0.03	-0.02	-0.01	-0.00	-0.00
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Free Cash Flow	-0.33	-0.95	-0.87	-0.04	-0.04
Free Cash Flow Per Share	-0.01	-0.03	-0.03	-0.00	-0.00
Gross Margin	67.88%	52.39%	89.72%	100.00%	85.14%
Operating Margin	-80.76%	-96.58%	-5507.63%	-269.34%	-608.24%
Profit Margin	-80.98%	-88.08%	-5507.01%	-269.34%	-586.97%
Free Cash Flow Margin	-32.24%	-116.12%	-11650.37%	-280.99%	-568.78%
EBITDA	-0.7	-0.65	-0.41	-0.04	-0.04
EBITDA Margin	-67.73%	-78.94%	-	-267.03%	-
D&A For EBITDA	0.13	0.14	0.01	0	0
EBIT	-0.84	-0.79	-0.41	-0.04	-0.05
EBIT Margin	-80.76%	-96.58%	-	-269.34%	-